FI890098A - Pyrazol- och indazolpyridinaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. - Google Patents

Pyrazol- och indazolpyridinaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. Download PDF

Info

Publication number
FI890098A
FI890098A FI890098A FI890098A FI890098A FI 890098 A FI890098 A FI 890098A FI 890098 A FI890098 A FI 890098A FI 890098 A FI890098 A FI 890098A FI 890098 A FI890098 A FI 890098A
Authority
FI
Finland
Prior art keywords
och
deras
indazolpyridinaminer
pyrazol
foerfarande foer
Prior art date
Application number
FI890098A
Other languages
English (en)
Other versions
FI890098A0 (fi
Inventor
Richard Charles Effland
Joseph Thomas Klein
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of FI890098A0 publication Critical patent/FI890098A0/fi
Publication of FI890098A publication Critical patent/FI890098A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI890098A 1988-01-11 1989-01-09 Pyrazol- och indazolpyridinaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. FI890098A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/141,852 US4806554A (en) 1988-01-11 1988-01-11 Pyrazol and indazolpyridinamines

Publications (2)

Publication Number Publication Date
FI890098A0 FI890098A0 (fi) 1989-01-09
FI890098A true FI890098A (fi) 1989-07-12

Family

ID=22497554

Family Applications (1)

Application Number Title Priority Date Filing Date
FI890098A FI890098A (fi) 1988-01-11 1989-01-09 Pyrazol- och indazolpyridinaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.

Country Status (14)

Country Link
US (1) US4806554A (fi)
EP (1) EP0324359A1 (fi)
JP (1) JPH01224372A (fi)
KR (1) KR890011875A (fi)
AU (1) AU613137B2 (fi)
DK (1) DK8589A (fi)
FI (1) FI890098A (fi)
HU (1) HU202229B (fi)
IL (1) IL88909A (fi)
NO (1) NO890096L (fi)
NZ (1) NZ227565A (fi)
PH (1) PH25293A (fi)
PT (1) PT89415B (fi)
ZA (1) ZA89154B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806554A (en) * 1988-01-11 1989-02-21 Hoechst-Roussel Pharmaceuticals, Inc. Pyrazol and indazolpyridinamines
US4868190A (en) * 1988-12-27 1989-09-19 Hoechst-Roussel Pharmaceuticals, Inc. N-pyridinyl-9H-carbazol-9-amines
US4916135A (en) * 1989-05-08 1990-04-10 Hoechst Roussel Pharmaceuticals Inc. N-heteroaryl-4-quinolinamines
US4983615A (en) * 1989-06-28 1991-01-08 Hoechst-Roussel Pharmaceuticals Inc. Heteroarylamino- and heteroaryloxypyridinamine compounds which are useful in treating skin disorders
US4983608A (en) * 1989-09-05 1991-01-08 Hoechst-Roussell Pharmaceuticals, Inc. N-substituted-4-pyrimidinamines and pyrimidinediamines
US5177088A (en) * 1991-04-17 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Substituted 3-(pyridinylamino)-indoles
US5674886A (en) * 1991-09-02 1997-10-07 Yamanouchi Pharmaceutical Co., Ltd. Triazolylated teritiary amine compound or salt thereof
JPH08277287A (ja) * 1995-02-09 1996-10-22 Mitsubishi Chem Corp インダゾール類およびその用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7006750A (fi) * 1969-05-13 1970-11-17
FR2479219A1 (fr) * 1980-04-01 1981-10-02 Nativelle Sa Ets Amino-alcoxy pyrazoles, procede pour leur preparation, et medicaments les contenant
AU7158881A (en) * 1980-07-30 1982-03-02 Dow Chemical Company, The Compounds and method for selectively controlling grassy weedsin rice
US4792562A (en) * 1985-12-04 1988-12-20 Hoechst-Roussel Pharmaceuticals, Inc. N-(pyrrol-1-yl)pyridinamines having memory enhancing activity
US4806554A (en) * 1988-01-11 1989-02-21 Hoechst-Roussel Pharmaceuticals, Inc. Pyrazol and indazolpyridinamines

Also Published As

Publication number Publication date
NO890096L (no) 1989-07-12
US4806554A (en) 1989-02-21
HU202229B (en) 1991-02-28
AU2836689A (en) 1989-07-13
DK8589A (da) 1989-07-12
ZA89154B (en) 1989-09-27
IL88909A0 (en) 1989-08-15
EP0324359A1 (en) 1989-07-19
HUT49131A (en) 1989-08-28
AU613137B2 (en) 1991-07-25
DK8589D0 (da) 1989-01-10
PH25293A (en) 1991-04-30
PT89415A (pt) 1990-02-08
KR890011875A (ko) 1989-08-23
JPH01224372A (ja) 1989-09-07
NO890096D0 (no) 1989-01-10
PT89415B (pt) 1993-09-30
FI890098A0 (fi) 1989-01-09
NZ227565A (en) 1991-09-25
IL88909A (en) 1993-01-31

Similar Documents

Publication Publication Date Title
FI893105A0 (fi) Tryckkapsel foer spraybehaollare och spraybehaollare som utnyttjar en saodan kapsel.
FI903929A0 (fi) Proteiner som induserar immunologisk effektorcellaktivation och kemattraktion.
FI902248A0 (fi) N-heteroaryl-4-kinolinaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI873002A (fi) Substituerade hydrazoner, foerfaranden foer deras framstaellning och deras anvaendning som bekaempningsmedel foer skadedjur.
FI871452A (fi) Faergloesa ketiminer, deras framstaellning och anvaendning som foernaetningsmedel.
FI906139A0 (fi) Halogenerade olefiner, foerfarande foer framstaellning av dessa och anvaendning av dessa som skadedjursbekaempningsmedel.
FI891222A (fi) Arylpiperazinylalkoxiderivat av cykliska imider, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI891411A (fi) Neopentylesterderivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI903214A0 (fi) Naftyl- och naftyloxi- pyrimidiner och dessa beroerande foereningar, foerfarande foer deras framstaellning och deras anvaendning som dermatologiska laekemedel.
FI905689A (fi) 3-aminopyrroler, foerfaranden foer deras framstaellning, och deras anvaendning som laekemedel.
FI875055A0 (fi) Optiskt aktiva gyras-inhibitorer, deras framstaellning och deras anvaendning som antibiotika.
FI904660A0 (fi) Som fungicider anvaendbara substituerade triazoler, deras framstaellning och kompositioner.
FI882443A (fi) Substituerade vinylkefalosporiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI905702A0 (fi) Kumarinderivat, foerfarande foer framstaellning av dessa, anvaendning av dessa och tiazolylaettikssyraderivat som mellanprodukter.
FI890098A (fi) Pyrazol- och indazolpyridinaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI872774A0 (fi) Bensimidazoler, deras framstaellning, formulering och anvaendning som inhibitorer foer magsyraavsoendring.
FI892207A (fi) 2-adamantyl-4-isotiazolin-3-oner, deras tillverkningsfoerfarande och anvaendning som baktericida och fungicida medel.
FI902852A0 (fi) Renininhibitoriska peptider, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI894677A (fi) Basiska 4-aryl-dhp-amider, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
FI902199A0 (fi) 5-substituerade 3-aryl-isoxazolderivat, deras framstaellning och deras anvaendning som skadedjursbekaempningsmedel.
FI881873A0 (fi) Kondenserade heteroalkylenkinolinaminer, foerfarande och mellanprodukter foer deras framstaellning och deras anvaendning som laekemedel.
FI891409A0 (fi) Dietylenglykolmonoestrar, foerfaranden foer deras framstaellning och deras framstaellning och deras anvaendning som laekemedel.
FI902177A0 (fi) Kompositioner som innehaoller elastomerer och icke-karboniserade, metaller innehaollande komplex.
FI874514A0 (fi) Halogensyklopropyl-foereningar, deras framstaellning och anvaendning som herbicida aemnen.
FI900102A (fi) 7-aryl- ochheteroaryletrar av desacetylforskolin, foerfrande foer deras framstaellning och deras anvaending som laekemedel.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED